{"id":"NCT00482170","sponsor":"Pfizer","briefTitle":"Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept","officialTitle":"A 3 Month, Randomised, Open Label, Parallel Group, Descriptive Study to Explore and Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (Etanercept Auto-injector and the Etanercept Prefilled Syringe) in Patients With Psoriasis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2009-04","completion":"2009-09","firstPosted":"2007-06-04","resultsPosted":"2012-03-30","lastUpdate":"2012-03-30"},"enrollment":421,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DEVICE","name":"Enbrel (etanercept)","otherNames":[]},{"type":"DEVICE","name":"Etanercept","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"Primary objective of this study is to compare patient satisfaction with the prefilled syringe (PFS) and the auto-injector (AI), two different delivery devices for etanercept after 12 weeks of use, using a 10 point scale form totally dissatisfied to totally satisfied.Secondary evaluation focus on the identification of patient and device attributes associated with patient satisfaction.","primaryOutcome":{"measure":"Participant Satisfaction With Injection Device Evaluated at Week 12 for Modified Intent-to-treat (mITT) Population","timeFrame":"Week 12","effectByArm":[{"arm":"Etanercept 50 mg Auto-injector","deltaMin":8.9,"sd":1.9},{"arm":"Etanercept 50 mg Prefilled Syringe","deltaMin":7.6,"sd":2.6}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":5},"locations":{"siteCount":78,"countries":["Belgium","Denmark","Finland","France","Germany","Greece","Hungary","Italy","Netherlands","Norway","Spain","Sweden"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":207},"commonTop":["Nasopharyngitis","Injection site reaction","Headache","Injection site erythema","Injection site pain"]}}